BEDFORD, Mass., April 12, 2017 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (Nasdaq:CFMS), a medical technology company that offers joint replacement implants customized to fit each patient's unique anatomy, ...
Independently verified assessment of the performance of the fully personalized iTotal CR system over a 7-year period confirms that it meets the panel’s demanding standards BILLERICA, Mass., Feb. 24, ...
BILLERICA, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (CFMS), a leading medical device company that features personalized knee and hip replacement products, today announced results of a ...
The United Kingdom's Orthopaedic Data Evaluation Panel (ODEP) has granted a 7A rating to Conformis Inc.'s iTotal CR (cruciate-retaining) knee replacement system. The rating is the result of an ...
BILLERICA, Mass., Jan. 30, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, ...
BILLERICA, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, recently launched a ...
Knee replacements are a fact of aging. Conformis, a Boston-based medical tech company, produced personalized joint replacement for knees and hips. The goal is less pain and faster recoveries. Eicoff ...
BILLERICA, Mass., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (CFMS), a leading medical technology company featuring personalized knee and hip replacement products, today announced the full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback